146 results
Page 5 of 8
DEFM14A
4zwq2c
6 Nov 18
Proxy related to merger
12:00am
424B3
zpqtthg8488i01kwi
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
25zdzvbekik
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-3.1
w867f36qbf0rdy
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.4
xhkuzyhmpbgz9 3k
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-2.1
o7t5uzp0dqdsklb
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.1
azioi8
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.2
o9mtr8 dmi4afelps
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.3
0867qhyp ixozacu8x
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-99.3
5fz6l7csf
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.1
azt95fv
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.4
7026sl0azbalfi41 lm8
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.2
m9rr80 zim
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.1
6w3hmzc2
9 Aug 18
Business combination disclosure
5:17pm
425
EX-3.1
n4v33y69b0
9 Aug 18
Business combination disclosure
5:17pm